Critical Care

official impact factor 4.60

This article is part of the supplement: Optimizing the use of carbapenems in the face of increasing Gram-negative resistance

Highly Access

Optimizing the use of carbapenems in the face of increasing Gram-negative resistance

Reuben Ramphal

Critical Care 2008, 12(Suppl 4):S1 doi:10.1186/cc6817

Accesses  

  • Last 30 days: 53 accesses
  • Last 365 days: 545 accesses
  • All time: 5528 accesses